TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Revenue	289.33	233.66	2.79	6.69	0.15	0.15	Upgrade
Revenue Growth (YoY)	3275.73%	8290.02%	-58.36%	4300.66%	0%	0%	Upgrade
Cost of Revenue	18.72	14.13	0.27	0.79	0	0	Upgrade
Gross Profit	270.62	219.53	2.52	5.9	0.15	0.15	Upgrade
Selling, General & Admin	129.22	122.71	70.01	128.09	107.85	15.03	Upgrade
Research & Development	93.05	76.19	125.35	222.58	165.9	154.18	Upgrade
Operating Expenses	222.26	198.9	195.36	350.67	273.75	169.21	Upgrade
Operating Income	48.36	20.63	-192.84	-344.77	-273.59	-169.06	Upgrade
Interest Expense / Income	12.06	12.62	10.19	5.64	6.33	5.29	Upgrade
Other Expense / Income	-5.32	-5.04	-4.7	-2.31	-0.54	-1.47	Upgrade
Pretax Income	41.62	13.06	-198.34	-348.1	-279.38	-172.87	Upgrade
Income Tax	0.42	0.39	0	0	0	0	Upgrade
Net Income	41.2	12.67	-198.34	-348.1	-279.38	-172.87	Upgrade
Shares Outstanding (Basic)	146	142	135	132	115	88	Upgrade
Shares Outstanding (Diluted)	146	149	135	132	115	88	Upgrade
Shares Change	4.20%	9.67%	2.41%	14.64%	30.51%	17.10%	Upgrade
EPS (Basic)	0.29	0.09	-1.46	-2.63	-2.42	-1.96	Upgrade
EPS (Diluted)	0.22	0.09	-1.46	-2.63	-2.42	-1.96	Upgrade
Free Cash Flow	20.28	-31.41	-176.18	-296.04	-214.86	-132.94	Upgrade
Free Cash Flow Per Share	0.14	-0.22	-1.30	-2.24	-1.86	-1.50	Upgrade
Gross Margin	93.53%	93.95%	90.48%	88.19%	100.00%	100.00%	Upgrade
Operating Margin	16.71%	8.83%	-6924.20%	-5154.28%	-179996.05%	-111220.39%	Upgrade
Profit Margin	14.24%	5.42%	-7121.54%	-5204.08%	-183803.29%	-113730.92%	Upgrade
Free Cash Flow Margin	7.01%	-13.44%	-6326.18%	-4425.70%	-141357.89%	-87458.55%	Upgrade
Effective Tax Rate	1.01%	2.99%	-	-	-	-	Upgrade
EBITDA	53.85	25.89	-187.84	-342.18	-272.89	-167.48	Upgrade
EBITDA Margin	18.61%	11.08%	-6744.74%	-5115.58%	-179535.53%	-110186.84%	Upgrade
Depreciation & Amortization	0.17	0.21	0.3	0.28	0.16	0.1	Upgrade
EBIT	53.68	25.68	-188.14	-342.46	-273.05	-167.58	Upgrade
EBIT Margin	18.55%	10.99%	-6755.62%	-5119.79%	-179639.47%	-110252.63%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).